Registry and analysis of Takotsubo Cardiomyopathy patients
Official title: Smidt Heart Institute Takotsubo Registry
Run by Cedars-Sinai Medical Center · NCT03910569 · Data updated 2026-11-12
This study is collecting information from people with Takotsubo Cardiomyopathy to see how the condition affects them and to help find better ways to treat it.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Cedars-Sinai Medical Center Academic / other |
| Locations | 1 site (Los Angeles, California) |
| Status | Recruiting |
| Started | January 3, 2019 |
| Main results expected | February 2029 |
| Study ends | February 2029 |
| Registry record updated | August 19, 2026 |
| Trial ID | NCT03910569 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals who have been diagnosed with Takotsubo Cardiomyopathy and can provide the necessary medical documentation.
✕Probably not a fit
Patients under 18 years old or those unable to provide informed consent or necessary documentation may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Cedars-Sinai Smidt Heart Institute is conducting an observational registry to collect both retrospective and prospective data on individuals diagnosed with Takotsubo Cardiomyopathy. This study aims to gather comprehensive demographic, clinical, and laboratory information, as well as therapy and outcome data, to better understand the condition. Participants will provide blood samples and clinical materials through a user-friendly online platform, allowing researchers to analyze data for identifying Takotsubo phenotypes and improving diagnostic and treatment strategies. The goal is to establish a large database that can help predict recurrence rates and develop targeted therapies.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic capabilities and targeted treatments for patients with Takotsubo Cardiomyopathy.
How similar studies have gone: Other studies have shown success in utilizing registries for similar cardiovascular conditions, indicating a promising approach for this novel study.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Have received a diagnosis of Takotsubo from their physician and consent to enroll * Submit full medical records needed for Takotsubo adjudication Exclusion Criteria: * Younger than 18 years * Unable to provide informed consent * Unable to provide the necessary documentation needed for screening purposes
Where it's running
-
Cedars Sinai Medical Center
Los Angeles, California, United States Recruiting
Study contacts
- Study coordinator: TS Registry
- Email: takotsuboresearch@cshs.org
- Phone: 310-248-8563
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Manganese MRI to image heart changes after takotsubo (broken heart) cardiomyopathy
This project will test whether manganese-enhanced cardiac MRI, together with common heart medications, can reveal ongoing heart muscle changes in adults with takotsubo (broken heart) cardiomyopathy.
-
Investigating heart issues in COPD patients during hospital stays
This study is trying to see if sudden worsening of COPD can cause heart problems in hospitalized patients and how it affects their recovery.
-
Resilience training for patients with heart disease
This study tests a resilience training program to see if it helps heart disease patients cope better with stress and improve their overall quality of life.
-
Using cardiac imaging to improve risk assessment in Takotsubo syndrome
This study is testing a new way to predict how well patients with Takotsubo syndrome will do in the hospital and over time by using heart imaging and comparing it to current methods.
-
Virtual support group for patients with Takotsubo syndrome
This study is testing if joining a virtual support group can help adults with Takotsubo syndrome feel less anxious after a year.
-
Using Cyclosporine to treat Takotsubo Syndrome
This study is testing if a medication called Cyclosporine can help people with Takotsubo syndrome recover better and have less heart damage compared to those who get a placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.